| Site Map |
| References |
| Glossary |
Healthcare
Professionals
Additional Materials
Home
| Hepatitis B Video |
| Materials to Download |
| Research |
| Additional Materials |
| Hepatitis B Treatment Product Information |
EPIVIR-HBV is indicated for the treatment of chronic hepatitis B associated with viral replication and active liver inflammation in adults and children 2-17 years.
Please click here to view the news article, "GlaxoSmithKline Study Shows Need for More Hepatitis B Education."
For more information about EPIVIR-HBV please visit our Customer Response Center.